{"id":"ik-3001","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Hypophosphatemia"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL5746480","moleculeType":null,"molecularWeight":"381.27"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"IK-3001 is a ferric carboxymaltose complex designed to deliver iron intravenously for rapid repletion of iron stores in iron deficiency anemia. The drug allows for high-dose iron administration in a single or limited number of infusions, bypassing gastrointestinal absorption limitations and improving patient compliance compared to oral iron supplementation.","oneSentence":"IK-3001 is an intravenous iron replacement therapy that replenishes depleted iron stores in patients with iron deficiency.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:15:31.796Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia in patients with chronic kidney disease"},{"name":"Iron deficiency anemia in patients intolerant to or with inadequate response to oral iron"}]},"trialDetails":[{"nctId":"NCT01959828","phase":"PHASE3","title":"Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2013-09","conditions":"Hypertension, Pulmonary, Ventricular Dysfunction, Left","enrollment":18}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["inhaled nitric oxide"],"phase":"phase_3","status":"active","brandName":"IK-3001","genericName":"IK-3001","companyName":"Mallinckrodt","companyId":"mallinckrodt","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IK-3001 is an intravenous iron replacement therapy that replenishes depleted iron stores in patients with iron deficiency. Used for Iron deficiency anemia in patients with chronic kidney disease, Iron deficiency anemia in patients intolerant to or with inadequate response to oral iron.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}